BackCity Therapeutics Overview
City Therapeutics Inc.

City Therapeutics Return on Equity

Valuation check: CTY's ROE is 17.74%, above the Healthcare sector average of 9.17%.

Get informed when a big investor buys or sells

+ Follow

ROE

17.74%

Return on Equity

17.74%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

City Therapeutics (CTY) FAQ

City Therapeutics (CTY) currently reports a ROE of 17.74%. That is above the Healthcare sector average of 9.17%. Use the charts on this page to explore City Therapeutics's ROE history and peer comparisons.

City Therapeutics's ROE of 17.74% is higher than the Healthcare sector average of 9.17%. That is roughly 93.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but City Therapeutics's current 17.74% should be judged against Healthcare norms (sector average: 9.17%) and against CTY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 17.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.17%. From there, open related valuation or income-statement pages for City Therapeutics, and consider following CTY for alerts when major investors trade the stock.

City Therapeutics is classified in the Healthcare sector. On ROE, it currently shows 17.74% versus a sector average near 9.17%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTY with unrelated industries.

Questions & Answers